Avantor (AVTR) Total Current Liabilities (2018 - 2026)
Avantor (AVTR) posted quarterly Total Current Liabilities of $1.4 billion for Q2 2026, down 46.34% year-over-year from $2.6 billion in Q2 2025, and up 1.08% quarter-over-quarter from $1.4 billion in Q1 2026.
Avantor (AVTR) Total Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $1.4 billion for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 46.34% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $1.4 billion (down 46.34% YoY), while the FY2025 annual figure was $1.4 billion, down 31.31% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $1.4 billion, up from $1.4 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $2.6 billion in Q2 2025, with the low at $1.4 billion in Q1 2026.
- The 5-year median for Total Current Liabilities is $1.5 billion (2023), against an average of $1.6 billion.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities jumped 75.86% in 2025, then plunged 46.34% in 2026.
- Avantor's Total Current Liabilities stood at $1.7 billion in 2022, then slipped by 10.76% to $1.5 billion in 2023, then jumped by 35.61% to $2.0 billion in 2024, then tumbled by 31.31% to $1.4 billion in 2025, then gained by 0.22% to $1.4 billion in 2026.
- Business Quant data shows AVTR's Total Current Liabilities at $1.4 billion in Q2 2026, $1.4 billion in Q1 2026, and $1.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Avantor | 9.62 Bn | 9.31 Bn | 537.00 Mn | 1.38 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Bn |
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.38 Bn |
| Sep 30, 2025 | 1.52 Bn |
| Jun 30, 2025 | 2.58 Bn |
| Mar 31, 2025 | 2.03 Bn |
| Dec 31, 2024 | 2.01 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.44 Bn |
| Dec 31, 2023 | 1.48 Bn |
| Sep 30, 2023 | 1.49 Bn |
| Jun 30, 2023 | 1.55 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jun 30, 2022 | 1.57 Bn |
| Mar 31, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.45 Bn |
| Sep 30, 2021 | 1.32 Bn |